SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
1,025.00    33.00 (3.33%)
Bid:
1,015.00
Ask:
1,030.00
Spread: 15.00 (1.478%)
Market Cap: £280.55m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

Value Creation Plan Crystallises

7 Jan 2013 07:00

RNS Number : 9097U
Gooch & Housego PLC
07 January 2013
 



For immediate release

7 January 2013

 

Gooch & Housego PLC

("G&H" or the "Company")

 

Value Creation Plan Crystallises

 

 

Gooch & Housego PLC, the specialist manufacturer of optical components & systems, announces that the Company's Value Creation Plan (VCP) crystallises today.

 

Further to the update issued on 4 October 2012, we are now able to provide details of the share option awards and share awards that will be made today. As a reminder, on 7 January 2010, following consultation with major shareholders, a share-based incentive scheme in the form of a VCP was put in place. At the same time approved share options were awarded under the Company Share Option Plan (CSOP) to UK-based participants. In accordance with the rules of the plan, on the third anniversary of the plan (today) the value created during the life of the plan, over and above a pre-determined threshold value based on a share price of £2.00, has been calculated and a share of that value (approximately 12%) will be distributed among the participating members of the senior management of the Company in the form of nil-cost share options (UK participants) and share awards (US participants). Half of the awards made today are exercisable immediately and the balance after twelve months, subject to certain conditions.

 

Details of the awards are as follows: -

 

Total number of market value CSOP share options awarded: 158,936

Total number of nil-cost share options and shares awarded: 1,380,566

 

In terms of dilutive effect, in aggregate these awards amount to 7% of the current issued share capital, although, as mentioned above, half the awards are not exercisable for twelve months.

 

Aggregate awards made to directors of the Company are as follows: -

 

Gareth Jones (CEO): 19,867 CSOP share options

450,747 Nil-cost share options

 

Terry Scribbins (COO) 19,867 CSOP share options

265,296 Nil-cost share options

 

Andrew Boteler (CFO) 19,867 CSOP share options

265,296 Nil-cost share options

 

Save for possibly some of the CSOP share options, the above directors are not planning to exercise any of their nil-cost options until June 2013 at the earliest.

 

For further information contact: -

 

Gareth Jones / Andrew Boteler

Gooch & Housego plc

01460 256440

Tim Thompson / Nicola Cronk

Buchanan

020 7466 5000

Patrick Robb/James Grace

Investec Bank plc

020 7597 5970

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUNVUROAAARAR
Date   Source Headline
23rd Jul 20127:00 amRNSProgress Update
12th Jun 20127:00 amRNSInterim Results
22nd May 20127:00 amRNSNotification of Interim Results
5th Apr 20127:00 amRNSHalf-Year Trading Update
14th Mar 20128:59 amRNSAIM Rule 20 - Annual Report
23rd Feb 201212:45 pmRNSAppointment of non-executive director
23rd Feb 20127:00 amRNSResults of Annual General Meeting
21st Feb 20127:00 amRNSTrading Update
29th Nov 20117:00 amRNSPreliminary Results
4th Nov 20114:35 pmRNSPrice Monitoring Extension
4th Oct 20117:00 amRNSFull-Year Trading Update
29th Sep 201111:52 amRNSBoard Change
8th Jun 20117:00 amRNSInterim Results
12th May 201112:24 pmRNSNotice of Results
1st Apr 20117:00 amRNSAcquisition and Trading Update
23rd Feb 20117:00 amRNSProgress Update for Today's Annual General Meeting
28th Jan 20118:10 amRNSDirector/PDMR Shareholding
25th Jan 20118:30 amRNSAcquisition of EM4
24th Jan 201112:07 pmRNSAdditional Listing
19th Jan 201111:45 amRNSUS Regulatory Approval
13th Jan 20114:55 pmRNSNotification of Interests
13th Jan 20114:55 pmRNSDirector Shareholdings
13th Jan 20114:53 pmRNSAdditional Listing
5th Jan 20111:42 pmRNSResult of EGM
16th Dec 20102:37 pmRNSProposed Acquisition, Placing and General Meeting
2nd Dec 20108:52 amRNSDividend
30th Nov 20107:00 amRNSPreliminary Results
15th Nov 20107:00 amRNSNotice of Results
5th Oct 20107:00 amRNSFull-Year Trading Update
17th Sep 20102:26 pmRNSHolding(s) in Company
13th Jul 20107:00 amRNSTrading Update
8th Jun 20107:00 amRNSInterim Results
18th May 20107:00 amRNSNotice of Results
8th Apr 20107:00 amRNSHalf-Year Trading Update
26th Mar 20103:33 pmRNSHolding(s) in Company
12th Mar 20108:56 amRNSDirector/PDMR Shareholding
25th Feb 201011:00 amRNSResult of AGM
24th Feb 20107:00 amRNSProgress Update for Today's Annual General Meeting
26th Jan 20108:24 amRNSDirector/PDMR Shareholding
18th Jan 20103:48 pmRNSAward of Share Options
7th Jan 20103:09 pmRNSAward of share-based incentives
1st Dec 20097:00 amRNSPreliminary Results
12th Nov 20098:56 amRNSNotice of Results
6th Oct 20097:00 amRNSFull-Year Trading Update
23rd Jul 20097:00 amRNSAppointment of new executive director
9th Jun 20097:00 amRNSInterim Results
13th May 20098:57 amRNSNotice of Results
2nd Apr 20097:00 amRNSResult of AGM
31st Mar 20097:00 amRNSHalf-Year Trading Update
23rd Mar 20097:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.